- Home
- SUPN vs WMK Comparison
SUPN vs WMK Comparison
Compare SUPN & WMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- WMK
- Stock Information
- Founded
- SUPN 2005
- WMK 1912
- Country
- SUPN United States
- WMK United States
- Employees
- SUPN N/A
- WMK N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- WMK Food Chains
- Sector
- SUPN Health Care
- WMK Consumer Staples
- Exchange
- SUPN Nasdaq
- WMK Nasdaq
- Market Cap
- SUPN 1.7B
- WMK 1.8B
- IPO Year
- SUPN 2012
- WMK N/A
- Fundamental
- Price
- SUPN $32.90
- WMK $76.10
- Analyst Decision
- SUPN Hold
- WMK
- Analyst Count
- SUPN 2
- WMK 0
- Target Price
- SUPN $36.00
- WMK N/A
- AVG Volume (30 Days)
- SUPN 787.3K
- WMK 157.2K
- Earning Date
- SUPN 05-07-2025
- WMK 05-07-2025
- Dividend Yield
- SUPN N/A
- WMK 1.83%
- EPS Growth
- SUPN 6500.00
- WMK 5.89
- EPS
- SUPN 1.32
- WMK 4.09
- Revenue
- SUPN $661,817,000.00
- WMK $4,791,730,000.00
- Revenue This Year
- SUPN N/A
- WMK N/A
- Revenue Next Year
- SUPN $8.67
- WMK N/A
- P/E Ratio
- SUPN $24.90
- WMK $18.62
- Revenue Growth
- SUPN 8.94
- WMK 1.64
- 52 Week Low
- SUPN $25.53
- WMK $60.39
- 52 Week High
- SUPN $40.28
- WMK $83.09
- Technical
- Relative Strength Index (RSI)
- SUPN 46.17
- WMK 50.78
- Support Level
- SUPN $31.69
- WMK $76.86
- Resistance Level
- SUPN $32.90
- WMK $80.61
- Average True Range (ATR)
- SUPN 0.96
- WMK 2.17
- MACD
- SUPN 0.29
- WMK -0.46
- Stochastic Oscillator
- SUPN 89.25
- WMK 26.74
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products consist of center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.